Global Intravenous Iron Therapy Market Growth (Status and Outlook) 2023-2029

Global Intravenous Iron Therapy Market Growth (Status and Outlook) 2023-2029

Iron is considered as an essential element which plays an important role in many vital biological processes such as the formation of myoglobin, neurotransmitter production, energy metabolism, the formation of collagen and immune system function, and others.Intravenous Iron Therapy is usually preferred over oral iron therapy. This is majorly due to the advantages of intravenous iron therapy, such as faster and higher increase in hemoglobin (Hb) levels and replenishment of body iron stores.

LPI (LP Information)' newest research report, the “Intravenous Iron Therapy Industry Forecast” looks at past sales and reviews total world Intravenous Iron Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Intravenous Iron Therapy sales for 2023 through 2029. With Intravenous Iron Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Iron Therapy industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Iron Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Iron Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Iron Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Iron Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Iron Therapy.

The global Intravenous Iron Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Intravenous Iron Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Intravenous Iron Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Intravenous Iron Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Intravenous Iron Therapy players cover American Regent, Inc., AMAG Pharmaceuticals, Inc, Fresenius Medical Care, Actavis Pharma, Inc. and Sanofi S.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Iron Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Iron Sucrose
Ferric Gluconate
Ferric Carboxymaltose
Ferumoxytol
Others

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
American Regent, Inc.
AMAG Pharmaceuticals, Inc
Fresenius Medical Care
Actavis Pharma, Inc.
Sanofi S.A.

Please note: The report will take approximately 2 business days to prepare and deliver.